Recent epidemiological evidence suggests that effects of cardiovascular risk factors may
vary depending on sex and age. In this study, we assessed the associations of metabolic …

The associations between sarcopenia and metabolic syndrome (MetS) in non-obese middle-
aged and older adults remain controversial. Thus, this meta-analysis aimed to evaluate the …

Background: Some studies have investigated the relationship between sarcopenia and
metabolic syndrome, and they have focused mainly on older subjects. Therefore, we …

Background Sarcopenia is a risk factor for metabolic disorders and cardiovascular disease,
but the association between sarcopenia and cardiovascular risk factors according to age …

Objective The purpose of this study was to examine whether muscle mass, muscle strength,
and physical performance were associated with metabolic syndrome (MetS) in community …

Background and aims Sarcopenia, the loss of skeletal muscle mass and strength, develops
with aging and may be a pivotal risk factor in individual cardiovascular diseases (CVDs). We …

Background Loss of muscle mass was reported to be associated with metabolic syndrome
(MetS), but little is known about the gender difference. Thus, the aim of this study was to …

Background Sarcopenia, the loss of muscle mass, contributes to various adverse health
outcomes in the elderly. It may be associated with cardiometabolic risk. The aim of this study …

Ageing, obesity and the metabolic syndrome (MetS) may all contribute to poor muscle health
(sarcopenia). This study aimed to determine the cross-sectional associations between MetS …

Aims Metabolic syndrome (MetS) increases the risk of diabetes mellitus (DM),
cardiovascular disease (CVD), cancer, and mortality. Sarcopenia has been reported as a …